Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Share-based Compensation (2016 - 2017)

Bone Biologics (BBLG) has disclosed Share-based Compensation for 2 consecutive years, with $209626.0 as the latest value for Q4 2017.

  • On a quarterly basis, Share-based Compensation fell 82.6% to $209626.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $1.6 million, a 61.02% decrease, with the full-year FY2025 number at $256358.0, up 35.77% from a year prior.
  • Share-based Compensation was $209626.0 for Q4 2017 at Bone Biologics, down from $367157.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $1.2 million in Q4 2016 to a low of $209626.0 in Q4 2017.